CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 129 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02910349
NCT02910349N/ACompleted

Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation - Echocardiography and Magnetic Resonance

Institute for Clinical and Experimental Medicine·observational·Posted Sep 22, 2016·Updated Mar 31, 2022

In Brief

An observational study for Aortic Valve Disorder. Completed, enrolled 129 participants across 5 sites in 2 countries.

Detailed Summary

Severe aortic regurgitation is a common valvular heart disease with prevalence of approximately 1%, affecting rather younger patients. The surgical treatment is the only causal treatment; it is recommended in patients with severe symptomatic aortic regurgitation. The optimal timing of the surgery is crucial because there is a certain risk of perioperative mortality and most patients require lifelong anticoagulation therapy. It is widely accepted, that asymptomatic patients with severely dilated left ventricle with systolic impairment have worse postoperative prognosis. We aim to evaluate native myocardial T1 relaxation time derived from cardiac magnetic resonance and global longitudinal left ventricular strain measured by echocardiography. These parameters are related to diffuse myocardial fibrosis and we expect to identify the cut off values, which correlate with further clinical course. This might enable better timing of the surgical treatment with the optimal postoperative left ventricular reverse remodelling and improved patient prognosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium, Czechia

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 22, 2016
Enrollment StartSep 1, 2015
Primary CompletionOct 1, 2021
Study CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 6.1 yearsPosted 9.8 years ago